COVID-19

新冠疫苗

Still the strongest tool against severe disease, hospitalisation, and long-term complications from COVID-19.

View provider information
Who it's for
Hong Kong’s June 2026 booster priority groups include elderly care-home residents, community-dwelling adults aged 65+, adults aged 50–64 with comorbidities, immunocompromised people aged 6 months+, pregnant women and healthcare workers. Priority-group status is clinical guidance, not confirmation of an available appointment.View full eligibility guidance ↗
Schedule
Boosters: the 2 June 2026 government advice recommends vaccination for priority groups at least six months after the last dose or infection, whichever is later. This is not a universal annual autumn schedule and does not confirm that service has resumed.View the full schedule ↗
Product reference
3 products
Comirnaty (BNT162b2) · Spikevax · CoronaVac

What is it?

COVID-19 vaccines are used to reduce the risk of severe COVID-19. Recommendations depend on age, health, vaccination and infection history; a circulating variant or historical product list alone does not determine the right vaccine for you.

Service check, 17 October 2026: CHP still reports a temporary suspension of the government COVID-19 vaccination service after the LP.8.1 supply expired. An expected resumption in the fourth quarter is not a confirmed reopening date. Check the official notice and provider for current service, formulation and supply.

Hong Kong guidance, eligibility and individual assessment

Hong Kong’s June 2026 booster priority groups include elderly care-home residents, community-dwelling adults aged 65+, adults aged 50–64 with comorbidities, immunocompromised people aged 6 months+, pregnant women and healthcare workers. Priority-group status is clinical guidance, not confirmation of an available appointment.

Ask a clinician to check your eligibility, vaccination and infection records. Government service is currently paused; suitability and actual supply for other groups or private options must be confirmed separately.

International reference (US CDC)

CDC’s 23 September 2026 US guidance recommends 2026/27 vaccination for adults aged 18+ and children aged 6 months–17 years with moderate or severe immunocompromise; other children in that age group use shared clinical decision-making. This US reference does not establish Hong Kong product indications, programme eligibility or supply.

Schedule

Boosters: the 2 June 2026 government advice recommends vaccination for priority groups at least six months after the last dose or infection, whichever is later. This is not a universal annual autumn schedule and does not confirm that service has resumed.

Initial vaccination, children’s schedules and immunocompromised schedules require a clinician to check the exact product, age, health and records.

Vaccine product reference

BrandManufacturer
Comirnaty (BNT162b2) · mRNAPfizer/BioNTech
Spikevax · mRNAModerna
CoronaVac · Inactivated whole virusSinovac

These product names are reference examples, not a complete list of registered products or confirmation of current supply. Confirm the exact product and availability with the provider.

Side effects

Most common reactions, lasting 1-2 days: sore arm, tiredness, headache, mild fever, muscle and joint aches.

Rare but documented: myocarditis or pericarditis (mostly in younger males, mostly mild). Severe allergic reaction is rare.

Common myths

  • Myth: COVID is over, I don't need a booster.

    Reality: COVID-19 can still cause severe disease. Assess booster need using priority-group guidance, health and vaccination/infection records, and check current service separately.

  • Myth: The vaccine causes long COVID.

    Reality: Evidence shows vaccinated people who get COVID are less likely to develop long COVID than unvaccinated people.

  • Myth: It alters your DNA.

    Reality: mRNA vaccines deliver instructions to produce a viral protein. The mRNA breaks down within days and never enters the cell nucleus where your DNA lives.

Cost and vaccination locations

Service check, 17 October 2026: CHP still reports a temporary suspension of the government COVID-19 vaccination service after the LP.8.1 supply expired. An expected resumption in the fourth quarter is not a confirmed reopening date. Check the official notice and provider for current service, formulation and supply.

When service resumes, check eligibility against the official venues and booking arrangements. For private enquiries, confirm the product, current supply, applicable ages, medical assessment and total fee; a historical product list is not proof of stock or free vaccination.

Sources

The review type is not recorded; this does not establish clinical review. Source checks are dated below. How sources are used

Related vaccines

Influenza (Flu)RSVPneumococcal

Related questions

Do mRNA vaccines change your DNA?Are side effects a sign something has gone wrong?Do I still need a vaccine if I've already had the infection?Is it safe to get several vaccines at the same time?Is it safe to be vaccinated during pregnancy?Can I get the flu and COVID vaccine on the same day in Hong Kong?

Prepare for your next conversation

Answer 6 to 7 short questions for a vaccine discussion list with reasons.

Start your vaccine planner ↗